Multi-Source Exosome Platform  A platform integrating R&D, customization, and quality management capabilities to provide high-quality biotech raw materials, manufacturing, sales, and integrated solutions.

/

    In the field of plant-derived extracellular vesicles, the company offers a diverse range of plant-sourced exosome series — including rice bran exosomes, sakura cell-derived extracellular vesicles, and other specialty botanical ingredients — widely applied in beauty and skincare, scalp care, and biotech product development. The company also possesses comprehensive customized development capabilities, enabling brand-tailored services such as plant source selection, functional direction planning, formulation design, and ODM/OEM integrated services, helping clients create products with market differentiation and brand distinction.

    U.S.PCPC approved ingredient : Oryza Sativa (Rice) Bran Vesicles  (INCI ID 40956)
/

    Human-Derived Exosome Platform

    Actively advancing next-generation biotech application research in the field of human-derived exosomes, encompassing human cell-derived exosomes and iPSC (induced pluripotent stem cell)-related exosomes. Combined with an international R&D perspective and process management, the company is committed to delivering biotech raw materials with safety, stability, and high added value — extending applications into premium skincare and regenerative technology sectors.
    U.S. PCPC approved ingredient : Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID 40983)

/

    Pet Exosome Platform

    Focused on the daily health care of dogs and cats, covering oral care, skin care, coat care, and cleansing & grooming series. By integrating exosome technology with botanical formulations and high-standard quality management, the company is dedicated to providing a gentler, more refined next-generation biotech care solution for pets — establishing a professional brand image in the pet exosome market. Customized development is also available based on client needs, including animal and pet source selection and requirement planning.
    Currently available supply : Canine-derived stem cell exosomes, Feline-derived stem cell exosomes, Milk exosomes.